GOT1 and cancer: GOT1 disruption in KRAS mutated cancer cells led to the up-regulated expression of the gluconeogenesis-pathway-gene glucose-6-phosphatase 3 (G6PC3) both during normal growth conditions and after glucose deprivation and the down-regulated expression of the glucose-controlling gene BIP after glucose deprivation, indicating GOT1’s roles in glucose metabolism (23).